Sunitinib Malate Yog CAS 441031-54-7

Sunitinib Malate Yog CAS 441031-54-7
Khoom Taw qhia:
Catalog Tsis yog.: SS123794
CAS TSIS MUAJ .: 341031-54-7
Purity: 98% min
Khoom npe: Malate
Daim Ntawv Pov Thawj: ISO9001
Molecular cov mis: c22h27fn4o2.c4h6o5
Molecular hnyav: 532.56
Txhais (s): Sunitinib L-Malate
Xa kev nug
Kev tsis
Hauj lwm lawm

 

Cov lus qhia

 

Kev piav txog Txiv kab ntxwv hmoov
Kev coj dawb huv 98% min
Ywg dej 0.5% max
Melting taw tes 189-191 degree
Residue ntawm ignition 0.2% max
Zoo tib yam impurities
Ib Leeg Cav 1.0% max
Tag nrho cov impurities 2.0% Max

 

Cov Ntaub Ntawv Thauj

 

Chaw ua uas tsis tau haus

Kev qhia tshwj xeeb

UN NUM

 

Hom

 

Cov Pab Pawg

 

Hs code

2933990099306

Ruaj khov & rov ua

Cov khoom lag luam ruaj khov nyob rau hauv cov qauv ambient ambient.

Chaw ntim khoom

Khaws kaw kom nruj. Khaws rau hauv qhov chaw txias thiab thaj chaw duab ntxoov ntxoo. Cia nyob rau hauv cov roj hauv qab. Pom zoo cia kub -25 - -15 degree.

Mob kom tsis txhob

 

Lub thawv

 

 

Cov ntaub ntawv raug

 

Chaw ua uas tsis tau haus

Kev qhia tshwj xeeb

Lub peev xwm

100kg / xyoo

Hov ntau

 

Lub teb chaws tseem ceeb

 

Peev Xwm / Batch

 

Paub lawm

Ntau lawm txij xyoo 2015

Ntxiv rau

 

 

 

 

Cov Ntawv Thov

 

1. Anticancer Kev Kho Mob

Sunitinib Malate yog qhov ntsuas cov qog nqaij hlav cancer siv feem ntau rau:

Lub cev ntawm lub cev Carcinoma (RCC)

Cov qog zom mov nruj zuj zus (gist)

Pancreatic Neuroendocrine hlav (Pnet)

Nws txwv cov qog nqaij hlav thiab angiogenesis los ntawm kev thaiv ntau tus receptor tyrosine kinases.

2. Ntau-tsom rau Tyrosine Kinase inhibitor

Lub hom phiaj ntau rtks suav nrog:

Vascular endothelial kev loj hlob ntawm cov neeg tau txais nyiaj (vegfr 1, 2, 3)

Platelig-derived Kev Loj Hlob Cov Khoom Siv (PDGFr thiab)

C-Kit

Flt3

Rov ua

Inhibition ntawm cov receptors cuam tshuam rau cov phiajcim kev taw qhia txoj kev tseem ceeb rau cov qog angiogenesis, proviferation, thiab metastasis.

3. Antiangiogenic Tus Neeg Sawv Cev

Los ntawm inhibiting vegfr thiab PDGFr, Sesitinib suppresses tsim cov hlab ntsha ntshav, tshaib plab cov hlav ntawm cov pa thiab cov as-ham.

 

Cov txiaj ntsig

 

✅ Ua tau zoo nyob rau hauv ntau hom cancer

FDA-pom zoo rau ntau tus mob cancer, ua rau muaj kev txhim kho muaj txoj sia nyob dawb thiab tag nrho cov neeg mob.

Qhia Txog Kev Sib Ntsib

Dosing qhov ncauj yooj yim tso cai rau kev kho mob sab nraud thiab txhim kho lub neej zoo.

✅ Ntau-hom phiaj ua

Cov Spectrum ntawm Kinase Inhibition txwv cov qog kom tiv thaiv thiab lub hom phiaj xob qog microenviror.

✅ Cov kws muag tshuaj zoo-kawm tau zoo

Paub tias yuav nqus tau, cov metabolism (feem ntau cyp3A4), thiab kev tshem tawm pab txhawb koob tshuaj.

 

Tag

 

Sunitinib Malate (CAS41031-54-7) yog ib qho kev kub ntxhov thiab muaj zog ntawm cov qog ntawm lub raum, thiab panceric neuroendocrine hlav. Nws lub peev xwm los ua ib txhij nkaus xwb hom phiajcim txoj hauv kev tseem ceeb rau cov qog nqaij hlav loj hlob thiab angiogenesis ua rau nws lub pob zeb ua rau mob cancer. Nrog kev tswj cov kev tswjfwm thiab qhov ncauj yooj yim, cov pej thuam sunitinib tseem ceeb qhia cov neeg mob kev saib xyuas cov neeg mob kev saib xyuas hauv oncology.

 

 

Cim npe nrov: Sunitinib Malate Yog 341031-54-7, Tuam Tshoj Sunitinib Malate 丨 CAS CAS 441031-54-7 Cov Chaw Tsim Khoom, Chaw muag khoom, Hoobkas

Xa kev nug
Tshaj koj qhov kev cia siab
Los ntawm Science mus rau Lub Neej nrog LEAPChem
tiv tauj peb